One Stop Shop for All Your Market Research Reports

Recombinant Human Erythropoietin Injection Market, Global Outlook and Forecast 2022-2028

Recombinant human erythropoietin injection (CHO cells) is clinically used for anemia caused by renal insufficiency, including hemodialysis, peritoneal dialysis and non dialysis patients with chronic renal failure. This report contains market size and forecasts of Recombinant Human Erythropoietin Injection in global, including the following market information: Global Recombinant Human Erythropoietin Injection Market Revenue, 2017-2022, 2023-2028, ($ millions) Global Recombinant Human Erythropoietin Injection Market Sales, 2017-2022, 2023-2028, (K Units) Global top five Recombinant Human Erythropoietin Injection companies in 2021 (%) The global Recombinant Human Erythropoietin Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028. The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028. 0.3ml Branch Segment to Reach $ Million by 2028, with a % CAGR in next six years. The global key manufacturers of Recombinant Human Erythropoietin Injection include Roche, LG Chem, Kexing Biopharm, 3SBio Group, Harbin Pharmaceutical Group Holding, Dong-E-E-Jiao, Humanwell Healthcare, Ncpc Genetech Biotechnology and Shandong E-hua Biotech Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue. The Recombinant Human Erythropoietin Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Recombinant Human Erythropoietin Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units) Global Recombinant Human Erythropoietin Injection Market Segment Percentages, by Type, 2021 (%) 0.3ml Branch 0.6ml Branch 1ml Branch Others Global Recombinant Human Erythropoietin Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units) Global Recombinant Human Erythropoietin Injection Market Segment Percentages, by Application, 2021 (%) Renal Failure Anemia Non Renal Anemia Global Recombinant Human Erythropoietin Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units) Global Recombinant Human Erythropoietin Injection Market Segment Percentages, By Region and Country, 2021 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Recombinant Human Erythropoietin Injection revenues in global market, 2017-2022 (Estimated), ($ millions) Key companies Recombinant Human Erythropoietin Injection revenues share in global market, 2021 (%) Key companies Recombinant Human Erythropoietin Injection sales in global market, 2017-2022 (Estimated), (K Units) Key companies Recombinant Human Erythropoietin Injection sales share in global market, 2021 (%) Further, the report presents profiles of competitors in the market, key players include: Roche LG Chem Kexing Biopharm 3SBio Group Harbin Pharmaceutical Group Holding Dong-E-E-Jiao Humanwell Healthcare Ncpc Genetech Biotechnology Shandong E-hua Biotech Pharmaceutical Intas Pharmaceuticals PeproTech WELLONA PHARMA SI HUAN SHENG WU Shanxi Weiqidaguangming Pharmaceutical
1 Introduction to Research & Analysis Reports 1.1 Recombinant Human Erythropoietin Injection Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Recombinant Human Erythropoietin Injection Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3250
Multi User US $4225
Corporate User US $4875
About this Report
Report ID 1153756
Category
  • Pharmaceuticals and Healthcare
Published on 30-Aug
Number of Pages 73
Publisher Name Market Monitor Global
Editor Rating
★★★★★
★★★★★
(28)